An NHS trust has published a shocking new finding.

An NHS trust has said that breast milk produced by trans women who were assigned male at birth is as good for babies as that produced by a mother who has given birth. In a letter to campaigners, the University of Sussex Hospitals NHS Trust (USHT), said that the milk produced by trans women after taking a combination of drugs is “comparable to that produced following the birth of a baby”.

The hospital trust, which runs Royal Sussex County Hospital, Worthing Hospital and Royal Alexandra Children’s Hospital among others, was also the first in Britain to use the term „chestfeeding” in place of breastfeeding, because it is considered by some to be more inclusive.

As is known, the trust created what it called Britain’s “first clinical and language guidelines supporting trans and non-binary birthing people” in 2021.

To lactate, one required drug is domperidone, which is often prescribed to women struggling to breastfeed, as it helps to stimulate the production of prolactin – a separate hormone that tells the body to produce milk. One problem is that domperidone is not intended for this, but is prescribed off-label by doctors, despite the manufacturer’s recommending against it because of possible side effects to a baby’s heart. However, for transgender people, it is an essential medicine that they take regularly, putting their children’s health at risk.